Impact of COVID-19 on patients with atopic dermatitis

Data on the tolerability and response to biologic therapies for type 2 immune disorders in the context of coronavirus disease 2019 (COVID-19) are currently lacking. Our survey aimed at assessing the adherence of patients to dupilumab therapy and the risk of the severe acute respiratory syndrome coro...

Full description

Saved in:
Bibliographic Details
Published in:Clin Dermatol
Main Authors: Grieco, Teresa, Chello, Camilla, Sernicola, Alvise, Muharremi, Rovena, Michelini, Simone, Paolino, Giovanni, Carnicelli, Giorgia, Pigatto, Paolo Daniele
Format: Artigo
Language:Inglês
Published: Elsevier Inc. 2021
Subjects:
COVID-19: Important updates and developments
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285243/
https://ncbi.nlm.nih.gov/pubmed/34920828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clindermatol.2021.07.008
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items